{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["active compounds", "atopic dermatitis", "pentaherbs", "therapeutic mechanisms"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32916837", "DateRevised": {"Year": "2020", "Month": "10", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "09", "Day": "09"}], "Language": ["eng"], "ELocationID": ["1166", "10.3390/plants9091166"], "Journal": {"ISSN": "2223-7747", "JournalIssue": {"Volume": "9", "Issue": "9", "PubDate": {"Year": "2020", "Month": "Sep", "Day": "09"}}, "Title": "Plants (Basel, Switzerland)", "ISOAbbreviation": "Plants (Basel)"}, "ArticleTitle": "The Active Compounds and Therapeutic Mechanisms of Pentaherbs Formula for Oral and Topical Treatment of Atopic Dermatitis Based on Network Pharmacology.", "Abstract": {"AbstractText": ["To examine the molecular targets and therapeutic mechanism of a clinically proven Chinese medicinal pentaherbs formula (PHF) in atopic dermatitis (AD), we analyzed the active compounds and core targets, performed network and molecular docking analysis, and investigated interacting pathways. Information on compounds in PHF was obtained from the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database, and target prediction was performed using the Drugbank database. AD-related genes were gathered using the GeneCards and Online Mendelian Inheritance in Man (OMIM) databases. Network analysis was performed by Cytoscape software and protein-protein interaction was analyzed by the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING). The Database for Annotation, Visualization and Integrated Discovery (DAVID) Bioinformatics Resources were applied for the enrichment analysis of the potential biological process and pathways associated with the intersection targets between PHF and AD. Autodock software was used to perform protein compound docking analysis. We identified 43 active compounds in PHF associated with 117 targets, and 57 active compounds associated with 107 targets that form the main pathways linked to oral and topical treatment of AD, respectively. Among them, quercetin, luteolin, and kaempferol are key chemicals targeting the core genes involved in the oral use of PHF against AD, while apigenin, ursolic acid, and rosmarinic acid could be used in topical treatment of PHF against AD. The compound-target-disease network constructed in the current study reveals close interactions between multiple components and multiple targets. Enrichment analysis further supports the biological processes and signaling pathways identified, indicating the involvement of IL-17 and tumor necrosis factor signaling pathways in the action of PHF on AD. Our data demonstrated the main compounds and potential pharmacological mechanisms of oral and topical application of PHF in AD."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faulty of Medical Technology, Shaanxi University of Chinese Medicine, Xianyang 712046, China."}], "LastName": "Chu", "ForeName": "Man", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong 999077, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants and Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, NT, Hong Kong 999077, China."}], "LastName": "Tsang", "ForeName": "Miranda Sin-Man", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faulty of Medical Technology, Shaanxi University of Chinese Medicine, Xianyang 712046, China."}], "LastName": "He", "ForeName": "Ru", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Quality Research in Chinese Medicines and Faculty of Medicine, Macau University of Science and Technology, Macau 999078, China."}], "LastName": "Lam", "ForeName": "Christopher Wai-Kei", "Initials": "CW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faulty of Medical Technology, Shaanxi University of Chinese Medicine, Xianyang 712046, China."}], "LastName": "Quan", "ForeName": "Zhi Bo", "Initials": "ZB"}, {"Identifier": ["0000-0002-5637-8331"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong 999077, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants and Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, NT, Hong Kong 999077, China."}, {"Identifier": [], "Affiliation": "Li Dak Sum Yip Yio Chin R & D Centre for Chinese Medicine, The Chinese University of Hong Kong, Shatin, NT, Hong Kong 999077, China."}], "LastName": "Wong", "ForeName": "Chun Kwok", "Initials": "CK"}], "GrantList": [{"GrantID": "20JK0608", "Agency": "Scientific Research Plan Projects of Shaanxi Education Department", "Country": ""}, {"GrantID": "Ref: ITS/457/18FX", "Agency": "the State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants (The Chinese University of Hong Kong/CUHK) and Innovation and Technology Fund Tier 2 from Innovation and Technology Commission, Hong Kong, and Li Dak Sum Y", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Plants (Basel)", "NlmUniqueID": "101596181", "ISSNLinking": "2223-7747"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Barbarot S., Auziere S., Gadkari A., Girolomoni G., Puig L., Simpson E.L., Margolis D.J., Bruin-Weller M., Eckert L. Epidemiology of atopic dermatitis in adults: Results from an international survey. Allergy. 2018;73:1284\u20131293. doi: 10.1111/all.13401.", "ArticleIdList": ["10.1111/all.13401", "29319189"]}, {"Citation": "Sophie N. Atopic Dermatitis: Global Epidemiology and Risk Factors. Ann. Nutr. Metab. 2015;66:8\u201316.", "ArticleIdList": ["25925336"]}, {"Citation": "Williams H.C. Clinical practice. Atopic dermatitis. N. Engl. J. Med. 2005;352:2314\u20132324. doi: 10.1056/NEJMcp042803.", "ArticleIdList": ["10.1056/NEJMcp042803", "15930422"]}, {"Citation": "Williams H.C. Is the prevalence of atopic dermatitis increasing? Clin. Exp. Dermatol. 2010;17:385\u2013391. doi: 10.1111/j.1365-2230.1992.tb00244.x.", "ArticleIdList": ["10.1111/j.1365-2230.1992.tb00244.x", "1486704"]}, {"Citation": "Wong G.W., Hui D.S., Chan H., Fok T., Zhong N., Chen Y., Lai C.K. Prevalence of respiratory and atopic disorders in Chinese schoolchildren. Chin. J. Tuberc. Respir. Dis. 2010;31:1225\u20131231. doi: 10.1046/j.1365-2222.2001.01140.x.", "ArticleIdList": ["10.1046/j.1365-2222.2001.01140.x", "11529892"]}, {"Citation": "Boguniewicz M., Leung D.Y.M. Atopic dermatitis: A disease of altered skin barrier and immune dysregulation. Immunol. Rev. 2011;242:233\u2013246. doi: 10.1111/j.1600-065X.2011.01027.x.", "ArticleIdList": ["10.1111/j.1600-065X.2011.01027.x", "PMC3122139", "21682749"]}, {"Citation": "Elias P.M., Hatano Y., Williams M.L. Basis for the barrier abnormality in atopic dermatitis: Outside-inside-outside pathogenic mechanisms. J. Allergy Clin. Immunol. 2008;121:1337\u20131343. doi: 10.1016/j.jaci.2008.01.022.", "ArticleIdList": ["10.1016/j.jaci.2008.01.022", "PMC2706021", "18329087"]}, {"Citation": "Liu F.T., Goodarzi H., Chen H.Y. IgE, Mast Cells, and Eosinophils in Atopic Dermatitis. Clin. Rev. Allergy Immunol. 2011;41:298\u2013310. doi: 10.1007/s12016-011-8252-4.", "ArticleIdList": ["10.1007/s12016-011-8252-4", "21249468"]}, {"Citation": "Jiao D., Wong C.K., Qiu H.N., Dong J., Cai Z., Chu M., Hon K.L., Tsang M.S.M., Lam C.W.K. NOD2 and TLR2 ligands trigger the activation of basophils and eosinophils by interacting with dermal fibroblasts in atopic dermatitis-like skin inflammation. Cell. Mol. Immunol. 2016;13:535\u2013550. doi: 10.1038/cmi.2015.77.", "ArticleIdList": ["10.1038/cmi.2015.77", "PMC4947824", "26388234"]}, {"Citation": "Alexander T., Maxim E., Cardwell L.A., Chawla A., Feldman S.R. Prescriptions for atopic dermatitis: Oral corticosteroids remain commonplace. J. Dermatol. Treat. 2017;29:238\u2013240. doi: 10.1080/09546634.2017.1365112.", "ArticleIdList": ["10.1080/09546634.2017.1365112", "28789575"]}, {"Citation": "Nghiem P., Pearson G., Langley R.G. Tacrolimus and pimecrolimus: From clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J. Am. Acad. Dermatol. 2002;46:228\u2013241. doi: 10.1067/mjd.2002.120942.", "ArticleIdList": ["10.1067/mjd.2002.120942", "11807435"]}, {"Citation": "Ashcroft D.M., Dimmock P., Garside R., Stein K., Williams H.C. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: Meta-analysis of randomised controlled trials. Br. Med. J. 2005;330:516\u2013525. doi: 10.1136/bmj.38376.439653.D3.", "ArticleIdList": ["10.1136/bmj.38376.439653.D3", "PMC552812", "15731121"]}, {"Citation": "Ormerod A.D. Topical tacrolimus and pimecrolimus and the risk of cancer: How much cause for concern? Br. J. Dermatol. 2005;153:701\u2013705. doi: 10.1111/j.1365-2133.2005.06899.x.", "ArticleIdList": ["10.1111/j.1365-2133.2005.06899.x", "16181449"]}, {"Citation": "Hon K.L.E., Leung T.F., Ng P.C., Lam M.C.A., Kam W.Y.C., Wong K.Y., Lee K.C.K., Sung Y.T., Cheng K.F., Fok T.F., et al. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: A randomized, double-blind, placebo-controlled study. Br. J. Dermatol. 2007;157:357\u2013363. doi: 10.1111/j.1365-2133.2007.07941.x.", "ArticleIdList": ["10.1111/j.1365-2133.2007.07941.x", "17501956"]}, {"Citation": "Hon K.L.E., Leung T.F., Wong Y., Lam W.K.C., Guan D.Q.B., Ma K.C., Sung Y.T.R., Fok T.F., Leung P.C. A Pentaherbs Capsule as a Treatment Option for Atopic Dermatitis in Children: An Open-Labeled Case Series. Am. J. Chin. Med. 2004;32:941\u2013950. doi: 10.1142/S0192415X04002545.", "ArticleIdList": ["10.1142/S0192415X04002545", "15673199"]}, {"Citation": "Chan B.C.L., Hon K.L.E., Leung P.C., Sam S.W., Fung K.P., Lee M.Y.H., Lau H.Y.A. Traditional Chinese medicine for atopic eczema: PentaHerbs formula suppresses inflammatory mediators release from mast cells. J. Ethnopharmacol. 2008;120:85\u201391. doi: 10.1016/j.jep.2008.07.034.", "ArticleIdList": ["10.1016/j.jep.2008.07.034", "18725279"]}, {"Citation": "Liu K.Y.P., Hu S.Q., Chan B.C.L., Wat E.C.L., Lau C.B.S., Hon K.L., Fung K.P., Leung P.C., Hui P.C.L., Lam C.W.K. Anti-Inflammatory and Anti-Allergic Activities of Pentaherb Formula, Moutan Cortex (Danpi) and Gallic Acid. Molecules. 2013;18:2483\u20132500. doi: 10.3390/molecules18032483.", "ArticleIdList": ["10.3390/molecules18032483", "PMC6270292", "23439564"]}, {"Citation": "Chan B.C., Li L.F., Hu S.Q., Wat E., Wong E.C., Zhang V.X., Lau C.B., Wong C.K., Hon K.L., Hui P.C., et al. Gallic Acid Is the Major Active Component of Cortex Moutan in Inhibiting Immune Maturation of Human Monocyte-Derived Dendritic Cells. Molecules. 2015;20:16388\u201316403. doi: 10.3390/molecules200916388.", "ArticleIdList": ["10.3390/molecules200916388", "PMC6331828", "26378505"]}, {"Citation": "Tsang M.S.M., Jiao D., Chan B.C.L., Hon K.L., Leung P.C., Lau C.B.S., Wong E.C.W., Cheng L., Chan C.K.M., Lam C.W.K., et al. Anti-Inflammatory Activities of Pentaherbs Formula, Berberine, Gallic Acid and Chlorogenic Acid in Atopic Dermatitis-Like Skin Inflammation. Molecules. 2016;21:519\u2013540. doi: 10.3390/molecules21040519.", "ArticleIdList": ["10.3390/molecules21040519", "PMC6274171", "27104513"]}, {"Citation": "Hopkins A.L. Network pharmacology: The next paradigm in drug discovery. Nat. Chem. Biol. 2008;4:682\u2013690. doi: 10.1038/nchembio.118.", "ArticleIdList": ["10.1038/nchembio.118", "18936753"]}, {"Citation": "Li S., Zhang B. Traditional Chinese medicine network pharmacology: Theory, methodology and application. Chin. J. Nat. Med. 2013;11:110\u2013120. doi: 10.3724/SP.J.1009.2013.00110.", "ArticleIdList": ["10.3724/SP.J.1009.2013.00110", "23787177"]}, {"Citation": "Li H., Zhao L., Zhang B., Jiang Y., Wang X., Guo Y., Liu H., Li S., Tong X. A network pharmacology approach to determine active compounds and action mechanisms of Ge-Gen-Qin-Lian decoction for treatment of type 2 diabetes. Evid.-Based Compl. Alt. Med. 2014;2014:495840. doi: 10.1155/2014/495840.", "ArticleIdList": ["10.1155/2014/495840", "PMC3914348", "24527048"]}, {"Citation": "Shen M., Tian S., Li Y., Li Q., Xu X., Wang J., Hou T. Drug-likeness analysis of traditional Chinese medicines: 1. property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines. J. Cheminform. 2012;4:31\u201336. doi: 10.1186/1758-2946-4-31.", "ArticleIdList": ["10.1186/1758-2946-4-31", "PMC3538521", "23181938"]}, {"Citation": "Trott O., Olson A.J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J. Comput. Chem. 2010;31:455\u2013461. doi: 10.1002/jcc.21334.", "ArticleIdList": ["10.1002/jcc.21334", "PMC3041641", "19499576"]}, {"Citation": "Huang T. A Handbook of the Composition and Pharmacology of Common Chinese Drugs. China Medical Science and Technology; Beijing, China: 1994."}, {"Citation": "Mehrbani M., Choopani R., Fekri A., Mehrabani M., Mosaddegh M., Mehrabani M. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial. J. Ethnopharmacol. 2015;172:325\u2013332. doi: 10.1016/j.jep.2015.07.003.", "ArticleIdList": ["10.1016/j.jep.2015.07.003", "26151244"]}, {"Citation": "Weng Z., Zhang B., Asadi S., Sismanopoulos N., Butcher A., Fu X., Katsarou-Katsari A., Antoniou C., Theoharides T.C. Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans. PLoS ONE. 2012;7:e33805. doi: 10.1371/journal.pone.0033805.", "ArticleIdList": ["10.1371/journal.pone.0033805", "PMC3314669", "22470478"]}, {"Citation": "Lee E.J., Ji G.E., Sung M.K. Quercetin and kaempferol suppress immunoglobulin E-mediated allergic inflammation in RBL-2H3 and Caco-2 cells. Inflamm. Res. 2010;59:847\u2013854. doi: 10.1007/s00011-010-0196-2.", "ArticleIdList": ["10.1007/s00011-010-0196-2", "20383790"]}, {"Citation": "Harwood M., Danielewska-Nikiel B., Borzelleca J.F., Flamm G.W., Williams G.M., Lines T.C. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food. Chem. Toxicol. 2007;45:2179\u20132205. doi: 10.1016/j.fct.2007.05.015.", "ArticleIdList": ["10.1016/j.fct.2007.05.015", "17698276"]}, {"Citation": "Hirano T., Higa S., Arimitsu J., Naka T., Ogata A., Shima Y., Fujimoto M., Yamadori T., Ohkawara T., Kuwabara Y. Luteolin, a flavonoid, inhibits AP-1 activation by basophils. Biochem. Biophys. Res. Commun. 2006;340:1\u20137. doi: 10.1016/j.bbrc.2005.11.157.", "ArticleIdList": ["10.1016/j.bbrc.2005.11.157", "16343431"]}, {"Citation": "Seelinger G., Merfort I., Schempp C. Anti-Oxidant, Anti-Inflammatory and Anti-Allergic Activities of Luteolin. Planta Med. 2008;74:1667\u20131677. doi: 10.1055/s-0028-1088314.", "ArticleIdList": ["10.1055/s-0028-1088314", "18937165"]}, {"Citation": "Liu B.L., Wu W.W., Tang N. Topical application of luteolin inhibits scratching behavior associated with allergic cutaneous reaction in mice. Planta Med. 2005;71:424\u2013428.", "ArticleIdList": ["15931580"]}, {"Citation": "Cortes J.R., Perez G.M., Rivas M.D., Zamorano J. Kaempferol inhibits IL-4-induced STAT6 activation by specifically targeting JAK3. J. Immunol. 2007;179:3881\u20133887. doi: 10.4049/jimmunol.179.6.3881.", "ArticleIdList": ["10.4049/jimmunol.179.6.3881", "17785825"]}, {"Citation": "Man M.Q., Hupe M., Sun R., Man G., Mauro T.M., Elias P.M. Topical Apigenin Alleviates Cutaneous Inflammation in Murine Models. Evid.-Based Complement. Alternat. Med. 2012;2012:912028. doi: 10.1155/2012/912028.", "ArticleIdList": ["10.1155/2012/912028", "PMC3524999", "23304222"]}, {"Citation": "Yano S., Umeda D., Yamashita S., Yamada K., Tachibana H. Dietary apigenin attenuates the development of atopic dermatitis-like skin lesions in NC/Nga mice. J. Nutr. Biochem. 2009;20:876\u2013881. doi: 10.1016/j.jnutbio.2008.08.002.", "ArticleIdList": ["10.1016/j.jnutbio.2008.08.002", "18993046"]}, {"Citation": "Ross J.A., Kasum C.M. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annu. Rev. Nutr. 2002;22:19\u201334. doi: 10.1146/annurev.nutr.22.111401.144957.", "ArticleIdList": ["10.1146/annurev.nutr.22.111401.144957", "12055336"]}, {"Citation": "Ikeda Y., Murakami A., Ohigashi H. Ursolic acid: An anti- and pro-inflammatory triterpenoid. Mol. Nutr. Food Res. 2010;52:26\u201342. doi: 10.1002/mnfr.200700389.", "ArticleIdList": ["10.1002/mnfr.200700389", "18203131"]}, {"Citation": "Shanmugam M.K., Dai X., Kumar A.P., Tan B.K., Sethi G., Bishayee A. Ursolic acid in cancer prevention and treatment: Molecular targets, pharmacokinetics and clinical studies. Biochem. Pharmacol. 2013;85:1579\u20131587. doi: 10.1016/j.bcp.2013.03.006.", "ArticleIdList": ["10.1016/j.bcp.2013.03.006", "23499879"]}, {"Citation": "Osakabe N., Yasuda A., Natsume M., Yoshikawa T. Rosmarinic acid inhibits epidermal inflammatory responses: Anticarcinogenic effect of Perilla frutescens extract in the murine two-stage skin model. Carcinogenesis. 2004;25:549\u2013557. doi: 10.1093/carcin/bgh034.", "ArticleIdList": ["10.1093/carcin/bgh034", "14729597"]}, {"Citation": "Trautmann A., Akdis M., Schmid-Grendelmeier P., Disch R., Br\u00f6cker E.B., Blaser K., Akdis C.A. Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis. J. Allergy Clin. Immunol. 2001;108:839\u2013846. doi: 10.1067/mai.2001.118796.", "ArticleIdList": ["10.1067/mai.2001.118796", "11692113"]}, {"Citation": "Wong W.J., Richardson T., Seykora J.T., Cotsarelis G., Simon M.C. Hypoxia-inducible factors regulate filaggrin expression and epidermal barrier function. J. Investig. Dermatol. 2015;135:454\u2013461. doi: 10.1038/jid.2014.283.", "ArticleIdList": ["10.1038/jid.2014.283", "PMC4286527", "24999590"]}, {"Citation": "Adler B.L., Friedman A.J. Nitric oxide therapy for dermatologic disease. Future Sci. OA. 2015;1:1\u20135. doi: 10.4155/fso.15.37.", "ArticleIdList": ["10.4155/fso.15.37", "PMC5137922", "28031861"]}, {"Citation": "Jacobi A., Antoni C., Manger B., Schuler G., Hertl M. Infliximab in the treatment of moderate to severe atopic dermatitis. J. Am. Acad. Dermatol. 2005;52:522\u2013526. doi: 10.1016/j.jaad.2004.11.022.", "ArticleIdList": ["10.1016/j.jaad.2004.11.022", "15761436"]}, {"Citation": "Manresa M.C., Smith L., Casals-Diaz L., Fagundes R.R., Brown E., Radhakrishnan P., Murphy S.J., Crifo B., Strowitzki M.J., Halligan D.N. Pharmacologic inhibition of hypoxia-inducible factor (HIF)-hydroxylases ameliorates allergic contact dermatitis. Allergy. 2019;74:753\u2013766. doi: 10.1111/all.13655.", "ArticleIdList": ["10.1111/all.13655", "30394557"]}, {"Citation": "Nograles K.E., Zaba L.C., Shemer A., Fuentes-Duculan J., Cardinale I., Kikuchi T., Ramon M., Bergman R., Krueger J.G., Guttman-Yassky E. IL-22\u2013producing \u201cT22\u201d T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17\u2013producing TH17 T cells. J. Allergy Clin. Immunol. 2009;123:1244\u20131252. doi: 10.1016/j.jaci.2009.03.041.", "ArticleIdList": ["10.1016/j.jaci.2009.03.041", "PMC2874584", "19439349"]}, {"Citation": "Ma L., Xue H.B., Guan X.H., Qi R.Q., An R.Z., Shu C.M., Zhang Y.J., Wei Y.H., Zhang J.H. Possible role of Th17 cells and IL-17 in the pathogenesis of atopic dermatitis in northern China. J. Dermatol. Sci. 2012;68:66\u201368. doi: 10.1016/j.jdermsci.2012.07.009.", "ArticleIdList": ["10.1016/j.jdermsci.2012.07.009", "22902077"]}, {"Citation": "Quondamatteo F. Skin and diabetes mellitus: What do we know? Cell Tissue Res. 2014;355:1\u201321. doi: 10.1007/s00441-013-1751-2.", "ArticleIdList": ["10.1007/s00441-013-1751-2", "24318789"]}, {"Citation": "Naeem A.S., Tommasi C., Cole C. A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic dermatitis. J. Allergy Clin. Immunol. 2017;139:1228\u20131241.", "ArticleIdList": ["PMC5380661", "27913303"]}, {"Citation": "Tamai K., Kaneda Y., Morishita R. Development of NF-kappa B decoy ointment and clinical trial for atopic dermatitis. Dermatitis. 2008;19:293\u2013294."}, {"Citation": "Melnik B.C. The potential role of impaired Notch signalling in atopic dermatitis. Acta Derm.-Venereol. 2015;95:5\u201313. doi: 10.2340/00015555-1898.", "ArticleIdList": ["10.2340/00015555-1898", "24853951"]}, {"Citation": "Navarini A.A., French L.E., Hofbauer G.F.L. Interrupting IL-6\u2013receptor signaling improves atopic dermatitis but associates with bacterial superinfection. J. Allergy Clin. Immunol. 2011;128:1128\u20131130. doi: 10.1016/j.jaci.2011.09.009.", "ArticleIdList": ["10.1016/j.jaci.2011.09.009", "21962991"]}, {"Citation": "Esparza-Gordillo J., Schaarschmidt H., Liang L. A functional IL-6 receptor (IL6R) variant is a risk factor for persistent atopic dermatitis. J. Allergy Clin. Immunol. 2013;132:371\u2013377. doi: 10.1016/j.jaci.2013.01.057.", "ArticleIdList": ["10.1016/j.jaci.2013.01.057", "23582566"]}, {"Citation": "Ru J., Li P., Wang J., Zhou W., Li B., Huang C., Li P., Guo Z., Tao W., Yang Y. TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. J. Cheminform. 2014;6:13\u201318. doi: 10.1186/1758-2946-6-13.", "ArticleIdList": ["10.1186/1758-2946-6-13", "PMC4001360", "24735618"]}, {"Citation": "Wishart D.S., Craig K., Guo A.C., Cheng D., Savita S., Dan T., Bijaya G., Murtaza H. DrugBank: A knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2007;36:D901\u2013D906. doi: 10.1093/nar/gkm958.", "ArticleIdList": ["10.1093/nar/gkm958", "PMC2238889", "18048412"]}, {"Citation": "Stelzer G., Rosen N., Plaschkes I., Zimmerman S., Twik M., Fishilevich S., Stein T.I., Nudel R., Lieder I., Mazor Y. The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. Curr. Protoc. Bioinform. 2016;54:30\u201338. doi: 10.1002/cpbi.5.", "ArticleIdList": ["10.1002/cpbi.5", "27322403"]}, {"Citation": "Hamosh A., Scott A.F., Amberger J.S., Bocchini C.A., McKusick A.V. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 2005;33:514\u2013517. doi: 10.1093/nar/gki033.", "ArticleIdList": ["10.1093/nar/gki033", "PMC539987", "15608251"]}, {"Citation": "Lopes C.T., Franz M., Kazi F., Donaldson S.L., Bader G.D. Cytoscape Web: An interactive web-based network browser. Bioinformatics. 2010;26:2347\u20132348. doi: 10.1093/bioinformatics/btq430.", "ArticleIdList": ["10.1093/bioinformatics/btq430", "PMC2935447", "20656902"]}, {"Citation": "von Mering C., Huynen M., Jaeggi D., Schmidt S., Bork P., Snel B. STRING: A database of predicted functional associations between proteins. Nucleic Acids Res. 2003;31:258\u2013261. doi: 10.1093/nar/gkg034.", "ArticleIdList": ["10.1093/nar/gkg034", "PMC165481", "12519996"]}, {"Citation": "Da W.H., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2008;4:44\u201357.", "ArticleIdList": ["19131956"]}, {"Citation": "Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., Bourne P.E. The Protein Data Bank. Nucleic Acids Res. 2000;28:235\u2013242. doi: 10.1093/nar/28.1.235.", "ArticleIdList": ["10.1093/nar/28.1.235", "PMC102472", "10592235"]}]}], "History": [{"Year": "2020", "Month": "7", "Day": "23"}, {"Year": "2020", "Month": "9", "Day": "3"}, {"Year": "2020", "Month": "9", "Day": "7"}, {"Year": "2020", "Month": "9", "Day": "12", "Hour": "1", "Minute": "1"}, {"Year": "2020", "Month": "9", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "13", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "9", "Day": "9"}], "PublicationStatus": "epublish", "ArticleIdList": ["32916837", "PMC7569866", "10.3390/plants9091166", "plants9091166"]}}]}